Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec;18(13):3702-10.
doi: 10.1245/s10434-011-1762-8. Epub 2011 May 18.

Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression

Affiliations

Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression

Nikol Snoeren et al. Ann Surg Oncol. 2011 Dec.

Abstract

Background: Local tumor progression (LTP) is a serious complication after local ablation of malignant liver tumors, negatively influencing patient survival. LTP may be the result of incomplete ablation of the treated tumor. In this study, we determined whether viable tumor cells attached to the needle applicator after ablation was associated with LTP and disease-free survival.

Methods: In this prospective study, tissue was collected of 96 consecutive patients who underwent local liver ablations for 130 liver malignancies. Cells and tissue attached to the needle applicators were analyzed for viability using glucose-6-phosphate-dehydrogenase staining and autofluorescence intensity levels of H&E stained sections. Patients were followed-up until disease progression.

Results: Viable tumor cells were found on the needle applicators after local ablation in 26.7% of patients. The type of needle applicator used, an open approach, and the omission of track ablation were significantly correlated with viable tumor tissue adherent to the needle applicator. The presence of viable cells was an independent predictor of LTP. The attachment of viable cells to the needle applicators was associated with a shorter time to LTP.

Conclusions: Viable tumor cells adherent to the needle applicators were found after ablation of 26.7% of patients. An independent risk factor for viable cells adherent to the needle applicators is the omission of track ablation. We recommend using only RFA devices that have track ablation functionality. Adherence of viable tumor cells to the needle applicator after local ablation was an independent risk factor for LTP.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flowchart study design
Fig. 2
Fig. 2
a HE coupe of morphologically intact tumor cells and stroma. b Black and white image of the same HE coupe, made with confocal microscope without light. c Image of tumorcells excited with light at 488 nm showing no autofluoresence (viable). d overlapping image of (b) and (c)
Fig. 3
Fig. 3
Level of autofluorescence intensities. Autofluorescence intensities ranging from 0–400 were considered viable
Fig. 4
Fig. 4
Kaplan–Meier curves depicting time to local tumor progression in the group with viable tumor cells and without

References

    1. Bruix J, Boix L, Sala M, et al. Focus on hepatocellular carcinoma. Cancer Cell. 2004;5:215–219. doi: 10.1016/S1535-6108(04)00058-3. - DOI - PubMed
    1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol. 2005;16:481–488. doi: 10.1093/annonc/mdi098. - DOI - PubMed
    1. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001;221:159–166. doi: 10.1148/radiol.2211001624. - DOI - PubMed
    1. Livraghi T, Solbiati L, Meloni F, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time approach”. Cancer. 2003;97:3027–3035. doi: 10.1002/cncr.11426. - DOI - PubMed
    1. Kuvshinoff BW, Ota DM. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery. 2002;132:605–611. doi: 10.1067/msy.2002.127545. - DOI - PubMed

MeSH terms